Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L-dopa and oligozoospermia.

J C Lavieri, A A Pierini

    Andrologia
    |January 1, 1978
    PubMed
    Summary

    Levodopa (L-Dopa) treatment showed a stimulatory effect on sperm production in men with idiopathic oligozoospermia. Both 500 mg and 750 mg daily doses improved sperm counts over two months.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extreme asthenozoospermia and chronic respiratory disease: a new variant of the immotile cilia syndrome.

    International journal of andrology·1990
    Same author

    Dysplasia of the fibrous sheath: an ultrastructural defect of human spermatozoa associated with sperm immotility and primary sterility.

    Fertility and sterility·1987
    Same author

    Male diabetic sexual impotence: effects of dopaminergic agents.

    Archives of andrology·1981
    Same author

    [L-dopa and oligospermia].

    Obstetricia y ginecologia latino-americanas·1977
    Same author

    Glycerylphosphorylcholine in human seminal plasma of normal subjects and sterile patients.

    Andrologia·1974
    Same author

    Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma.

    Cancer·1970

    Area of Science:

    • Reproductive Medicine
    • Endocrinology
    • Clinical Pharmacology

    Background:

    • Idiopathic oligozoospermia is a common cause of male infertility.
    • Spermatogenesis regulation involves complex hormonal pathways, including the hypophysis.
    • Limited therapeutic options exist for idiopathic oligozoospermia.

    Purpose of the Study:

    • To investigate the efficacy of Levodopa (L-Dopa) in treating idiopathic oligozoospermia.
    • To evaluate the impact of different L-Dopa dosages on sperm production.
    • To explore the potential mechanism of L-Dopa's action on spermatogenesis.

    Main Methods:

    • A clinical investigation involving 39 male patients with idiopathic oligozoospermia and primary sterility.
    • Patients were divided into two groups: one receiving 500 mg/day of L-Dopa, the other 750 mg/day.
    • Treatment duration for both groups was two months, with outcomes assessed monthly.

    Main Results:

    • The group receiving 500 mg/day showed 14 improvements in sperm parameters, with 9 noted at month one and 5 at month two.
    • The group receiving 750 mg/day observed 8 improvements, with 5 in the first month and 3 in the second.
    • Similar positive results were noted for longer treatment durations.

    Conclusions:

    • Levodopa (L-Dopa) demonstrates a potential stimulatory effect on spermatogenesis in patients with idiopathic oligozoospermia.
    • The hypophysis may be involved in mediating L-Dopa's positive impact on sperm production.
    • L-Dopa presents a promising therapeutic agent for male infertility due to low sperm count.

    Related Experiment Videos